Key statistics
As of last trade Immunovia AB (publ) (IMMNOV BTU:STO) traded at 1.36, -7.48% below its post-IPO high of 1.47, set on Sep 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.34 |
---|---|
High | 1.37 |
Low | 1.30 |
Bid | 1.34 |
Offer | 1.36 |
Previous close | 1.34 |
Average volume | 1.49m |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 23 2024 14:08 BST.
More ▼
Press releases
- Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
- Immunovia Publishes Interim Report for January-June 2024
- Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health
- Immunovia files US patent application to protect its next-generation test
- Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy
- Invitation to Immunovia's Q2 presentation
- Immunovia presents data from discovery study at 2024 PancreasFest medical conference
- Immunovia's new lab staffed and operational after rapid implementation
More ▼